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Abstract
In state-dependency, information retrieval is most efficient when the animal is in the same state as it was during the
information acquisition. State-dependency has been implicated in a variety of learning and memory processes, but its
mechanisms remain to be resolved. Here, mice deficient in AMPA-type glutamate receptor GluA1 subunits were first
conditioned to morphine (10 or 20 mg/kg s.c. during eight sessions over four days) using an unbiased procedure, followed
by testing for conditioned place preference at morphine states that were the same as or different from the one the mice
were conditioned to. In GluA1 wildtype littermate mice the same-state morphine dose produced the greatest expression of
place preference, while in the knockout mice no place preference was then detected. Both wildtype and knockout mice
expressed moderate morphine-induced place preference when not at the morphine state (saline treatment at the test); in
this case, place preference was weaker than that in the same-state test in wildtype mice. No correlation between place
preference scores and locomotor activity during testing was found. Additionally, as compared to the controls, the knockout
mice showed unchanged sensitization to morphine, morphine drug discrimination and brain regional m-opioid receptor
signal transduction at the G-protein level. However, the knockout mice failed to show increased AMPA/NMDA receptor
current ratios in the ventral tegmental area dopamine neurons of midbrain slices after a single injection of morphine
(10 mg/kg, s.c., sliced prepared 24 h afterwards), in contrast to the wildtype mice. The results indicate impaired drug-
induced state-dependency in GluA1 knockout mice, correlating with impaired opioid-induced glutamate receptor
neuroplasticity.
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Introduction
In state-dependency, information retrieval is most efficient when
the animal is in the same state as it was during the information
acquisition. State-dependency has been implicated across species
(human, [1]; rodent, [2]; C. elegans, [3]) and with various states
[1,4], including those induced by drugs [5]. Drugs induce an
internal state (an affect) that can act as a cue in learning process:
when an animal learns a behavior while intoxicated, it later better
recalls the behavior while being again intoxicated. Drug-induced
state-dependency might, thus, underlie behaviors that are driven
by drug-associated cues, e.g. drug-induced relapses in addicted
individuals [6,7]. However, the molecular correlates of state-
dependency remain to be resolved.
Glutamate receptors of a-amino-3-hydroxy-5-methyl-4-isoxazo-
lepropionic acid (AMPA) type (for review, see [8]) possess a dual
role in neuronal communication. First, they are mediators of fast-
acting excitatory neurotransmission, and second, changes in their
regulation constitute a molecular mechanism of neuronal adap-
tation underlying long-term potentiation, a putative cellular
correlate of learning and memory [9]. More specifically, AMPA
receptor GluA1 subunit-deficient mouse line (GluA12/2 mice)
shows adaptation-dependent defects at neuronal circuitry [10] and
behavioral [11] levels, suggesting that GluA1 subunit has a major
role in neuronal adaptation.
GluA1 subunit has been proposed to play a role in the
adaptation processes mediating the initial steps that eventually
lead to compulsive drug use [12]. GluA12/2 mice show various
phenotypes related to substance abuse as they i) fail to show
cocaine-induced enhancement in AMPA/NMDA ratio in ventral
tegmental area dopamine cells (VTA DA cells) [13], ii) display a
specific impairment in stimulus reward learning by showing no
conditioned reinforcement and abnormal second-order respond-
ing [14] and iii) express deficient morphine- and benzodiazepine-
induced adaptation during development of tolerance and in
withdrawal phase [15,16].
Here, we studied drug-induced state-dependency using mor-
phine as a state-forming stimulus in place conditioning setting. In
GluA12/2 mice, the expression of morphine-conditioned place
preference was tested with or without morphine to assess state-
dependent testing conditions. We also studied the detection of
morphine stimulus in drug discrimination paradigm, and mor-
phine action in various brain regions using opioid-stimulated G-
protein neurochemical assay. VTA DA neuronal plasticity induced
by a single morphine injection was examined by electrophysio-
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logical ex vivo slice recordings. Our results suggest a role of AMPA
receptors in morphine-induced state-dependency.
Materials and Methods
Ethics
All experimental procedures in this study were carried out with
the approved permissions (ESAVI-0010026/041003/2010 and
ESAVI-2010-05600/Ym-23) and had ethical approval from the
State Provincial Government of Southern Finland. All efforts were
made to minimize the number and suffering of animals.
Animals
GluA12/2 mouse line was generated as described [10]. GluA1
line was backcrossed to C57BL/6J mouse line (Harlan BV., Horst,
The Netherlands) at least 7 times prior to use. For the experiments,
the GluA12/2 mice and the GluA1+/+ littermate controls were
from heterozygous breedings. The animals were genotyped using
PCR from tail-tip biopsy samples as described [10]. In the
behavioral experiments, the animals were housed 2–4 animals to a
cage from weaning, until used at the age of 2.5–4 months. All
animals were naı¨ve to pharmacological and handling manipula-
tions until the start of the experiments. In the electrophysiological
experiments, the animals were used at the time after weaning, at
the age of 20–26 days. The animal facility had lights on from 6
a.m. until 6 p.m., temperature set at 2061uC and relative
humidity at 5061%. Water and standard rodent food pellets
(Harlan) were available ad libitum. All the experiments were
performed during the light phase between 8 a.m. and 13 a.m.
Altogether 156 GluA1+/+ (76 females, 80 males) and 129
GluA12/2 (60 females, 69 males) animals were used.
Morphine injections
Morphine hydrochloride (Yliopiston apteekki, Helsinki, Finland)
was daily dissolved in 0.9% NaCl solution (saline) and injected
subcutaneously in a volume of 10 ml/kg, unless otherwise stated.
Control animals were injected with equal volumes of saline.
Conditioned place preference paradigm
Conditioning and place preference testing was performed in
eight polycarbonate cages (45622.5615 cm; Tecniplast, Buguggi-
ate, Italy) covered with transparent lids with ventilation holes. The
cage floors were covered with either one of the two materials,
which acted as conditioning stimuli: plastic material consisting of
1.2-cm-wide flat bars separated by 0.5 cm from each other and
metal grid material of stainless steel wire mesh with 1-mm holes.
These materials were selected from several different materials in
15-min preliminary pre-conditioning preference tests using a
separate batch of naı¨ve GluA12/2 and GluA1+/+ mice so that
the animals showed no preference for either of them (data not
shown). Locomotor activity (distance traveled in meters) and
location of each mouse in place preference test (time spent in the
morphine-associated side) was determined by Ethovision 3.0 video
tracking system (Noldus Information Technology BV., Wagenin-
gen, The Netherlands) based on video image analysis of the center-
point of the mouse. Between the trials all cages and floor materials
were thoroughly washed with water and dried to remove the
odors. The whole experiment was repeated 5 times using different
animals with all groups being present in each sub-experiment, and
the results were finally combined.
In the conditioning phase, two 30-min trials were performed per
day on four consecutive days resulting in total of eight
conditioning trials. Each day, in the first trial, saline injection
was paired with either plastic or grid floor (CS2 trial, conditioning
stimulus with saline). In the second trial 4 h after the first one,
morphine (10 or 20 mg/kg) was paired with the other floor type
(CS+ trial, conditioning stimulus with morphine), so that half of
the animals received morphine paired with plastic and the other
half with grid. Immediately after the injections the mice were
placed to the cages for 30 min. To ascertain that mice expressed
no preference for either floor material, also control animals of both
mouse lines were included, always receiving saline paired with
both materials throughout the trials.
Place preference test was performed two days after the last
conditioning trial at 10 a.m. The cage floor was covered with both
plastic and grid materials, thereby bisecting it into two distinct
equally-sized zones without any vertical borders between them.
Thus, during both the place preference test trial and conditioning
trials the area of the arena was identical, i.e. the animals had
access to the whole apparatus during all phases of the experiment.
Spatial orientation of the materials was balanced for the test
groups. The animals were injected with saline or a priming dose of
morphine (10 mg/kg), thus creating saline-state (Sal-state) or
morphine 10 mg/kg-state (Mor10-state), respectively, and placed
in the center of the cage. Locomotor activity and location of the
mouse were observed for 15 min. Place preference was presented
as time spent in the morphine-associated zone.
Locomotor activity of young 20- to 26-day-old GluA12/2 and
GluA1+/+ mice was determined without injections for 30 min as
reported above for the conditioning trial activity.
Drug discrimination paradigm
Drug discrimination training was conducted in operant
chambers (Med-Associates, Georgia, VT, USA) enclosed in
ventilated sound-attenuating cubicles. The chambers were
equipped with two retractable levers, an amber stimulus light
above each lever, and a white houselight located on the opposite
wall. The reinforcer was sweetened condensed milk (To¨rsleffs,
Haugen –Gruppen Oy, Vantaa, Finland) diluted 1:2 in water and
delivered at a volume of 25 ml in a drinking cup located between
the levers.
Mice were food restricted to an average 2.6 g of chow per day
resulting to 85% of free feeding body weight for the duration of the
experiment. Mice were trained to discriminate 5 mg/kg morphine
from saline administered 20 min before start of the discrimination
session. Twenty-min sessions were conducted Monday through
Friday during the light period of the light-dark cycle, one session
per day. Mice were initially trained to lever press for sweetened
condensed milk after administration of 0 or 1 mg/kg morphine
under a fixed ratio (FR) schedule 1. The morphine dose was
gradually increased to 5 mg/kg and the response requirement to
FR 5. This training procedure was adopted because of problems
with nonexistent responding when training was started with the
5 mg/kg dose and FR 5 requirement. Morphine and saline were
administered in a pseudorandom order and the positions of
morphine and saline levers were counterbalanced among mice.
Each training session started with the illumination of the
houselight and the stimulus lights above the levers. Upon
completion of the response requirement on the correct lever, the
reinforcer was delivered and the houselight as well as the stimulus
light above the correct lever were extinguished for 3.5 s.
Discrimination training between 0 and 5 mg/kg morphine
under FR 5 schedule was considered stable when the following
criteria were met for at least four out of five consecutive sessions: 1)
$10 reinforcers earned per session, 2) first completed response
requirement on the correct lever, and 3) $80% correct total
responses. After these criteria were met, mice were tested with 0,
2.5, 5, and 10 mg/kg of morphine to generate a dose-response
GluA1 and State-Dependency
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function. The morphine doses were administered in a within-
subjects Latin square design. Each test session was preceded by
two training sessions (one morphine, one saline session) satisfying
the criteria stated above. If the criteria were not satisfied during
these two sessions, animals were required to meet the criteria
above for 4 out of 5 consecutive sessions before testing continued.
Electrophysiology
Young mice (20–26 days old) were injected i.p. either with
10 mg/kg of morphine or saline. The brains were dissected out
20–30 h later and cut into slices, and whole-cell patch-clamp
recordings of VTA dopamine neurons were conducted as
previously described in [17]. In short, the horizontal slices
containing the VTA were prepared in cutting solution containing
(in mM): 60 NaCl, 2 KCl, 8 MgCl2, 0.3 CaCl2, 30 NaHCO3, 1.25
NaH2PO4, 140 sucrose, 10 D-glucose. Recordings were made in
carbogen-bubbled artificial cerebrospinal fluid (ACSF, containing
(in mM): 126 NaCl, 1.6 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.5
CaCl2, 18 NaHCO3, and 11 D-glucose. ACSF was perfused over
the slice at the rate of 2 ml/min. The drugs used in the recordings
were diluted to the ACSF. Electrodes had a resistance of 3–5 MV
when filled with internal solution containing (in mM): 130 cesium
methanesulfonic acid, 10 HEPES, 0.5 EGTA, 8 NaCl, 5 QX314,
4 MgATP, 0.3 MgGTP, 10 BAPTA (pH 7.2–7.25), osmolarity
27865 mOsm.
VTA in horizontal brain slices was recognized as an area medial
to the substantia nigra compacta and medial to the terminal
nucleus of the accessory optic tract. The neuron was identified as
dopaminergic, if there was a clear hyperpolarization-activated
cation-current (Ih-current) seen after hyperpolarizing the cell in 10-
mV steps to 2130 mV [18–20].
Excitatory postsynaptic currents (EPSCs) were evoked by
electrical pulses delivered at 0.1 Hz frequency (stimulator S-900,
Cornerstone by Dagan) through a bipolar stimulus electrode.
Picrotoxin (100 mM) was added to the ACSF to block GABAA
receptors. The recordings were performed in voltage clamp
configuration at +40 mV (Axopatch 200B, Axon Instruments,
Union City, CA, USA) [20]. The stable baseline EPSCs were
recorded for 5–10 min. Then, 100 mM DL-AP5 was added to
perfusion solution to block NMDA receptors, and after 5 min, the
remaining current representing AMPA receptor-mediated current
was recorded for 5–10 min with continued presence of DL-AP5.
The recordings were filtered at 1 kHz and digitized at 20 kHz
(Digidata 1322A, Axon Instruments). To calculate the AMPA/
NMDA ratio, first the average AMPA receptor-mediated current
was subtracted from the average baseline EPSC, revealing the
NMDA receptor-mediated current, and then the AMPA/NMDA-
ratio was calculated from the peak amplitudes of the currents. One
to two cells (only one cell per slice) were studied per mouse. The
recordings from different cells from the same animal were
averaged and this average was used in the analysis. The drugs
used in electrophysiology were purchased from Tocris Bioscience
(Bristol, UK).
m-Opioid receptor agonist-stimulated GTPc[35S]
autoradiography
Guanosine 59-(c-[35S]thio)triphosphate (GTPc[35S]) autoradi-
ography was performed as described earlier [21] with minor
modifications. GluA1+/+ and GluA12/2 mice were decapitated,
their brains removed, and frozen on dry ice and stored at 280uC.
Coronal sections of 14 mm were cut using a cryostat (Leica CM
3050 S, Leica Microsystems, Nussloch, Germany), thaw-mounted
on Superfrost slides (Mentzel-Glaeser, Brauschweig, Germany)
and stored at 280uC. Air-dried sections were surrounded by
hydrophobic pen (Daido Sangyo Co., Tokyo, Japan). Sections
were preincubated at 20uC for 20 min in 50 mM Tris-HCl
(pH 7.4), 1 mM EDTA, 100 mM NaCl and 5 mM MgCl2 in a
volume of 0.95 ml per slide. Thereafter, in the second preincu-
bation, the sections were loaded with 2 mM guanosine diphos-
phate (GDP) in the same buffer for 60 min at 20uC in the presence
of 1 mM adenosine A1 receptor blocker 8-cyclopentyl-1,3-dipro-
pylxanthine (DPCPX, Tocris). DPCPX was added to reduce the
extensive basal activity of adenosine receptors [22]. The final 90-
min incubation with GTPc[35S] (54–68 pM; Perkin Elmer,
Boston, USA) took place in the buffer supplemented with 2 mM
GDP, 1 mM dithiothreitol, 1 mM DPCPX and various concen-
trations of DAMGO (0.1–10 mM, Tyr-D-Ala-Gly-N-methyl-Phe-
Gly-ol) or morphine (10 mM), in the presence and absence of
10 mM naltrexone. Nonspecific binding was defined in the
presence of 10 mM unlabeled GTPcS. The sections were washed
twice for 5 min at 0uC in 50 mM Tris-HCl (pH 7.4) and 5 mM
MgCl2, and dipped in distilled water at 0uC, before drying under a
fan at room temperature. The sections were exposed to film
(Kodak BioMax MR, Eastman Kodak, Rochester, USA) at 8uC
for 4 days together with [14C]-standards (GE Healthcare,
Buckinghamshire, UK), and thereafter films were developed.
Films were digitized and binding densities of the sections
quantified using Dage MTI camera system (DAGE-MTI Inc.,
Michigan City, USA) combined with MCID Elite M5+ 4.0
software (Imaging Research Inc., St. Catharines, Canada) with
[14C]-standards, which were used to convert optical density values
to radioactivity values. Non-specific binding values were subtract-
ed from all other values. DAMGO-stimulation data were fitted for
EC50 and maximal stimulation (maximal DAMGO-induced
stimulation expressed as a percentage of that observed with basal
GTPc[35S] binding) values by nonlinear regression analysis using
GraphPad Prism 5.0 software (GraphPad Software, San Diego,
CA, USA). The chemicals in the autoradiographic assay were
from Sigma (St. Louis, MO, USA) unless otherwise stated.
Statistics
Data were analyzed with either two- or three-way ANOVA with
repeated measures when applicable, followed by either post hoc
Bonferroni test (more than two groups) or by independent samples
unpaired t-test (two groups). Correlations between locomotor
activity and place preference during the place preference test were
calculated using Pearson’s correlation. Statistical analyses were
performed by using the statistical software packages SPSS 15.0 for
Windows (SPSS, Chicago, IL, USA) and the Prism 5.0 program
(GraphPad Software). Statistical significance was set at p,0.05.
Data from both sexes were pooled unless otherwise stated. Data
are expressed as means 6 standard errors of the mean (SEM).
Results
Locomotor activity in conditioning trials
Figure 1A–C represents an overview of the locomotor activities
throughout the whole conditioning process in GluA1+/+ and
GluA12/2 mice. GluA12/2 animals were hyperactive at the
beginning of the eight-trial conditioning phase relative to GluA1+/
+ animals (saline-treated control mice, genotype effect,
F1,50 = 28.49, p,0.001), but habituated gradually to the level of
GluA1+/+ mice (genotype6trial interaction, F7,350 = 18.15,
p,0.001). No habituation was seen in GluA1+/+ mice (trial
effect, p.0.05), with their locomotor activity remaining constant
throughout the saline trials (see also Figs. 2A and 2C). No
significant sex effects or interactions were found in place
preference experiments (statistics not shown).
GluA1 and State-Dependency
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Figure 1. Distance moved during each of the eight conditioning trials for the GluA12/2 (2/2) mice and their littermate wildtype
GluA1+/+mice (+/+). In CS+ trials, animals were injected with saline (saline control animals) (A), morphine 10 mg/kg (B) or morphine 20 mg/kg (C)
immediately before transferring them into cages, in which their locomotor activity was recorded for 30 min. Saline was injected in CS2 trials. Data
represent means6 SEM, n= 24–49. *p,0.05, **p,0.01, ***p,0.001, between the genotypes, t-test. S = Saline; 10 and 20 denote doses of morphine in
mg/kg.
doi:10.1371/journal.pone.0038325.g001
Figure 2. Morphine-induced locomotor sensitization in GluA12/2 and GluA1+/+ mice. (A–B), Distance moved in the CS+ (morphine, or
saline for saline control animals) trials is shown. The scores indicate 1) significant morphine effects and dose-response (#p,0.05, ##p,0.01,
###p,0.001, compared to the previous dose, Bonferroni test), 2) significant locomotor sensitization to morphine (&p,0.05, &&p,0.01, &&&p,0.001,
compared to the previous day, Bonferroni test), 3) significant habituation in GluA1—mice (saline control group) (HHp,0.01, compared to the first trial,
Bonferroni test). Data represent means 6 SEM, n= 24–49. *p,0.05, **p,0.01, ***p,0.001, between the genotypes, t-test. The scores were derived
from the raw data depicted in Fig. 1. (C–D), The difference in distance moved between trials 1 and 2 (CS+ minus CS2) on each conditioning day. The
data indicate 1) that the activity of GluA12/2 is strongly reduced, in comparison to GluA1+/+ mice, during the second trial of the first conditioning
day after both saline control and morphine injections (*p,0.05, **p,0.01, ***p,0.001, between the genotypes, t-test), 2) that during the following
days, GluA12/2 and GluA1+/+ mice were equally activated by 10 mg/kg morphine and 3) that morphine 20 mg/kg produced incremental
locomotor activity in both mouse lines (#p,0.05, ##p,0.01, ###p,0.001, compared to the previous dose, Bonferroni test). Data represent means6
SEM, n= 24–49. The scores were derived from the raw data depicted in Fig. 1.
doi:10.1371/journal.pone.0038325.g002
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Figure 2A–B displays the effects of morphine and saline on
locomotor activity during the four CS+ conditioning trials.
Morphine increased locomotor activity in a dose-dependent
manner in both genotypes (conditioning dose effect,
F2,170 = 49.34, p,0.001). Morphine effect on locomotor activity
was increased progressively after each conditioning trial (day
effect, F3,510 = 41.00, p,0.001). The dose of 20 mg/kg produced a
greater sensitization than the dose of 10 mg/kg (day6conditioning
dose interaction, F6,510 = 27.90, p,0.001).
To take into account the different baseline activities of the
GluA1+/+ and GluA12/2 mice, difference scores between each
CS+ and corresponding CS2 trials were calculated within mouse
lines (Fig. 2C–D). In concordance with the data in Fig. 2A–B,
morphine-induced activation was dose-dependent (conditioning
dose effect, F2,170 = 61.02, p,0.001), and the animals sensitized to
morphine (day effect, F3,510 = 131.73, p,0.001) in a dose-
dependent manner (day6conditioning dose interaction,
F6,510 = 30.10, p,0.001). However, the first morphine dose failed
to activate the GluA12/2 mice (genotype effect and day6
genotype interaction, F1,170 = 7.53, p,0.01 and F3,510 = 17.66,
p,0.001, respectively).
Place preference test
In the Sal-state, both GluA1+/+ and GluA12/2 mice
expressed place preference that was dependent on the morphine
conditioning dose (Fig. 3A; conditioning dose effect, F2,158 = 4.26,
p,0.05). After the conditioning dose of 10 mg/kg, GluA1+/+
mice did not display place preference in the Sal-state (p = 0.3),
whereas GluA12/2 mice showed a significant preference
(however, no significant genotype difference here). After the
conditioning dose of 20 mg/kg, slightly less place preference was
observed in GluA12/2 mice compared to GluA1+/+ mice
(p,0.05, t-test). In the Mor10-state, the place preference was
either increased or decreased depending on the conditioning dose
(conditioning dose6testing state interaction, F2,158 = 3.82,
p,0.05). In GluA1+/+ mice, testing in Mor10-state increased
place preference as compared to testing in Sal-state in mice
conditioned with 10 mg/kg morphine, but decreased the prefer-
ence in mice conditioned with 20 mg/kg morphine. However,
GluA12/2 mice expressed no place preference when tested in
Mor10-state independent of the conditioning dose (10 and 20 mg/
kg) (genotype6conditioning dose6testing state interaction,
F2,158 = 5.40, p,0.01).
In Sal-state, locomotor activity during the preference test was at
higher level in GluA12/2 mice than GluA1+/+ mice (Fig. 3B;
genotype effect, F1,158 = 49.00, p,0.001), indicative of the
phenotypical hyperactivity of the GluA12/2 mice. However,
no difference was detected between those groups that had received
saline during all conditioning trials (t-test, p.0.05), indicative of
complete habituation in the GluA12/2 mice. In GluA1+/+ mice
in the Sal-state, locomotor activity decreased in the animals
conditioned with 20 mg/kg morphine (conditioning dose effect,
F2,158 = 5.07, p,0.01), but no such difference was detected in
GluA12/2 mice (genotype6conditioning dose interaction,
F2,158 = 4.22, p,0.05). Testing in Mor10-state increased locomo-
tor activity in both mouse lines as compared to testing in Sal-state
(testing state effect, F1,158 = 68.11, p,0.001). This increase in
locomotor activity also was dependent on genotype and condi-
tioning dose (genotype6conditioning dose6testing state interac-
tion, F2,158 = 3.63, p,0.05): no increase was observed in mice that
had received saline in all conditioning trials, but the morphine-
conditioned GluA12/2 mice moved more than the correspond-
ing GluA1+/+ mice.
Because alterations in locomotor activity during the place
preference testing trials could possibly affect the expression of
place preference [23], correlations between the place preference
scores and the locomotor activities during the tests were
determined. For both GluA12/2 and GluA1+/+ mice, Pearson
correlation coefficients were calculated for each conditioning dose
in two ways: first, separately for the groups tested in Sal-state and
Mor10-state, and second, by pooling both state groups. In both
cases the highest correlation score found was 0.43 (p.0.05), and
thus in neither case were the correlations significant between the
preference scores and locomotor activities (p.0.05, data not
shown).
Morphine discrimination
Using the drug discrimination paradigm, we aimed to compare
the detection of internal opioid signals in GluA12/2 and
GluA1+/+ mice. In discrimination training, both genotypes
equally learned to discriminate morphine during the 40 training
sessions (genotype effect, F1,12 = 0.15, p.0.05). Females reached
the training criteria in fewer sessions than males (sessions to reach
criteria were 61 and 35 for males and females, respectively; sex
effect, F1,12 = 6.45, p,0.05). However, no genotype6sex interac-
tion was found (F1,12 = 1.25, p.0.05). Of a total of 21 animals, 5
failed to reach the training criteria for reliable morphine
discrimination in 40 training session (three female GluA1+/+
mice and one male and one female GluA12/2 mouse) and were
therefore excluded from the analyses.
After the discrimination training, dose-response tests were
performed. Figure 4A shows the morphine dose-response function
with morphine-appropriate responding during the 20-min session.
There was a significant dose effect (F3,21 = 14.59, p,0.001) with
higher morphine doses producing higher morphine-appropriate
responding. However, no genotype (F1,7 = 0.72, p.0.05) or sex
(F1,7 = 0.07, p.0.05) effects and no interactions (p’s.0.05) were
found. Figure 4B shows that response rates declined with
increasing morphine dose (dose effect, F3,21 = 6.51, p,0.01).
There were no significant effects of sex (F1,7 = 0.01, p.0.05) or
genotype (F1,7 = 1.88, p.0.05) and no significant interactions
(p’s.0.05). Statistical analysis for both the morphine-appropriate
responding and the response rate data were also performed
without the data for the highest morphine testing dose (10 mg/kg)
which tended to produce non-responding behavior in both
genotypes. These analyses, however, revealed no significant
genotype differences (data not shown).
AMPA/NMDA ratio of VTA dopamine neurons
By measuring AMPA/NMDA ratio, we wanted to compare the
strength of glutamate synapses of VTA DA cells 24 h after a single
in vivo injection of morphine (10 mg/kg) to young GluA12/2and
GluA1+/+ mice. The mouse lines responded differently to the
treatment (genotype6drug interaction, F1,27 = 20.32, p,0.001). In
GluA1+/+ mice, morphine strongly increased AMPA/NMDA
ratio (drug effect, F1,27 = 14.14, p,0.01), as shown in Figure 5.
However, no such increase was detected in GluA12/2 mice.
However, after saline injection, the baseline AMPA/NMDA ratio
was higher in GluA12/2 than in GluA1+/+ mice (p,0.05).
To determine the basal locomotor behavior of young (P20–26,
the age also used for electrophysiology) GluA12/2 and GluA1+/
+ mice, a 30-min locomotor activity test was run in exactly the
same conditions as the place conditioning described above. As in
the adult mice, locomotor activity of the young GluA12/2 mice
(115.066.3 m) was greater than that of GluA1+/+ mice
(48.262.6 m) (genotype effect, F1,31 = 98.61, p,0.001). Young
GluA12/2 mice were, thus, moving 2.40 times more than
GluA1 and State-Dependency
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GluA1+/+ mice, the ratio being almost identical to that in adults
(2.43 times more) treated with saline during the first conditioning
trial. No significant effect of sex or genotype6sex interaction was
found (p.0.05).
m-Opioid receptor G-protein activation
By using the GTPc[35S] autoradiographic analysis, we aimed to
assess the brain regional m-opioid receptor signal transduction at
the G-protein level in GluA12/2 and GluA1+/+ mice.
Representative autoradiographs are depicted in Figure 6. Basal
and non-specific bindings were equal in both genotypes and sexes
across all brain regions (data not shown). In DAMGO-stimulated
regional EC50-values (Table 1), no statistically significant differ-
ences were detected between genotypes or sexes (p’s.0.05).
However, the EC50 value was higher in the VTA than in the
amygdala, caudate-putamen, hypothalamus, locus coeruleus,
nucleus accumbens and thalamus (ANOVA for region
F9,86 = 3.71, p,0.01, followed by Bonferroni test) suggesting lower
potency for DAMGO in the VTA. In maximal stimulation
(Table 1), no differences were observed between genotypes or
sexes in any of the brain regions studied (p’s.0.05). GTPc[35S]
binding stimulated by 10 mM morphine was similar between
GluA12/2 and GluA1+/+ mice in all brain regions studied (data
not shown).
Discussion
In the present study, we found that morphine state-dependency
was altered in the mouse line lacking the GluA1 subunit of the
AMPA-type glutamate receptor. State-dependency was probed in
three conditions: Firstly, when adult GluA1+/+ mice were tested
in a state (Mor10-state) equal to the conditioning state, they
expressed a significant place preference. However, GluA12/2
mice failed to show place preference in this condition. Secondly,
both lines conditioned with 20 mg/kg morphine, and tested in
Mor10-state (now mice received half of the conditioning dose and
Figure 3. State-dependency is impaired in GluA12/2mice in morphine-conditioned place preference. (A) Time spent in the morphine-
associated zone during 15 min (900 s). Animals were tested either in Sal-state (priming injection of saline) or in Mor10-state (priming injection of
10 mg/kg morphine). (B) Distance moved during the 15 min preference test. Data represent means 6 SEM, n= 8–33. *p,0.05, ***p,0.001, between
the genotypes, t-test; $p,0.05, $$p,0.01, $$$p,0.001, between testing states, t-test; #p,0.05, ##p,0.01, between conditioning doses, compared to
saline control, Bonferroni test; &p,0.05, between conditioning doses, compared to morphine 10 mg/kg conditioning dose, Bonferroni test.
Sal = Saline, Mor =Morphine.
doi:10.1371/journal.pone.0038325.g003
Figure 4. Unaltered detection of opioid stimulus in GluA12/2
mice. Mice were trained to discriminate 5 mg/kg morphine from saline
and then tested for various doses of morphine in a 20-min drug
discrimination test session. (A) Dose-response curves for discriminative
stimulus effects of morphine; data show morphine-appropriate lever
responses expressed as percentage of total responses on both levers.
(B) Dose-response curves for response rate-lowering effects of
morphine during the dose-response tests. Data are shown as means
6 SEM, n=5–6.
doi:10.1371/journal.pone.0038325.g004
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thus were in a different state) failed to express place preference.
Thirdly, some expression of morphine-induced place preference
was detected in both mouse lines after being conditioned with
morphine (10 or 20 mg/kg) and tested in Sal-state. These data
indicate that a testing dose equal to conditioning dose (i.e. state-
dependency) produces the greatest expression of place preference,
also demonstrated by others in the place preference paradigm
[24,25]. Importantly, these data suggest a deficit in opioid state-
dependency in the GluA12/2 mouse line.
Studies elaborating state-dependency with drug-induced place
conditioning are sparse (see [26]), but some other methods have
been used, e.g. operant food-reinforced system [5] and passive
avoidance [27]. The data presented here show similar pattern of
state-dependency as these previous observations using other
methods, that is, the greatest responding is acquired in the same
drug state while out-of-state responding is lower, but not non-
existent [5,27]. Morphine-induced state-dependency has been
shown to rely on selectivity of opioid receptors, and on various
other neurotransmitter systems, such as the DA system, in the
brain [5,27,28]. Our data point to a significant role of AMPA-type
glutamate receptors in state-dependency.
Detection of opioid stimulus was found to be intact in GluA12/2
mice, since these mice were able to discriminate between the levers
associated with morphine and saline when different doses of morphine
were administered at the drug discrimination test. The GluA12/2
mice learned the food-reinforced lever-pressing similarly to their
wildtype controls, thus providing a stable platform to study drug
discrimination and confirming the previous data that GluA1
subunit is not critical in learning the simple food-reinforced
lever-pressing task [14]. Unchanged perception of morphine
effects by these mice was indicated by the unchanged dose-
response of morphine-appropriate responding. To our knowl-
edge, these are the first morphine discrimination studies
reported for mice. Importantly, most opioid-related mechanisms
and processes that have been studied, have been unaltered in
the GluA12/2 mice. They have unaltered pharmacodynamics
evidenced by unchanged m-opioid receptor signaling at the G-
protein level in various brain regions (the present study),
morphine-induced sensitization and morphine-induced analgesia
[16] and pharmacokinetics evidenced by unchanged morphine
concentrations in blood and brain tissue after acute administra-
tion [16]. Thus, the target systems for morphine appear to be
normally functional in the GluA12/2 mice.
Patch-clamp recordings, performed in young mice (P20–26),
revealed that the VTA DA neurons of the GluA12/2 mice failed
to show glutamate receptor neuroplasticity in the same manner as
those of GluA1+/+ mice after a single morphine administration.
This deficient neuroplasticity has been observed in the GluA12/
2 mice also after cocaine administration [13]. The elevation of
AMPA/NMDA receptor current ratio is considered to represent
NMDA receptor-dependent long-term potentiation (LTP) in the
VTA [20,29]. Activation of VTA DA neurons by the drugs of
abuse elevates the level of GluA1 subunit in the VTA [30,31].
According to the current hypothesis, the activation of VTA DA
neurons leads to a fast insertion of calcium-permeable non-GluA2
subunits (GluA1, GluA3 or GluA4) to their afferent synapses,
which provide an additional source of calcium, leading to LTP
[32–34]. Impaired LTP may be more general in the GluA12/2
mice, as LTP is also absent in the hippocampal CA1 area of these
mice [10]. The baseline AMPA/NMDA ratio of the GluA12/2
mice was elevated, in agreement with Dong et al. [13]. The
mechanism of this alteration is not known and interestingly,
genome-wide expression profiling has revealed no upregulation of
GluA3 (or ectopic GluA4) expression, but apparently compensa-
tory upregulation of calcium channels in the GluA12/2 mice
[35]. It should be noted that, in addition to changes in excitatory
inputs to VTA DA neurons, the global knockout of GluA1 subunit
in GluA12/2 mice might have induced some unknown changes
during nervous system development. Nevertheless, the maximal
elevation in the AMPA/NMDA ratio was unlikely reached in
GluA12/2 mice since the morphine-induced AMPA/NMDA
ratio was higher in GluA1+/+ mice than in GluA12/2 mice.
Besides state-dependency, the current experiments also enabled
to examine reward behavior in the absence of GluA1 subunit-
containing AMPA receptors. No deficit in the morphine-induced
place preference in GluA12/2 mice in the undrugged test
situation (Sal-state) was found, suggesting that these mice are
capable of learning the CS-US association and express normal
place preference. Results from earlier conditioned place prefer-
ence studies with GluA12/2 mice using cocaine are inconsistent,
reporting either a deficit [13] or no deficit [36,37] in the
expression of cocaine-conditioned place preference. However,
these results are dependent upon the design of the experiment.
The deficit in place preference was only observed when using a
biased apparatus with non-counterbalanced (biased) subject
assignment [13], which both are factors that complicate the
interpretation of the place preference data [38]. This precaution is
important especially in the case of morphine that can exert
anxiolytic effects [39]. The present experiments were designed to
Figure 5. Lack of morphine-induced increase in the ventral
tegmental area dopamine neuron AMPA/NMDA ratios in
GluA12/2 mice. A single morphine (10 mg/kg) or saline injection
was administered one day before ex vivo electrophysiological
recordings from slices. (A) Representative traces displaying AMPA and
NMDA receptor-mediated current components. (B) Quantification of
the electrophysiological data, which is represented as means 6 SEM,
n= 6–11. *p,0.05, between the genotypes; ##p,0.01, compared to the
corresponding saline control, Bonferroni test.
doi:10.1371/journal.pone.0038325.g005
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exclude the apparatus bias over the conditioning phase by
inclusion of saline-saline control animals. In agreement with our
findings, the pharmacological approach using AMPA receptor
antagonists suggests that these receptors are dispensable in drug-
induced conditioned place preference, as long as the ligands are
selective to the AMPA receptors and do not affect the NMDA
receptor functions [37,40,41].
The neurobiological control of locomotor activity, either
spontaneous or that initiated by the drugs of abuse, has previously
been suggested to arise, at least partly, from the mesolimbic
dopamine system [42]. The GluA12/2 mice show a robust
endophenotype of novelty-induced hyperactivity in the present
data and in [16,43], an observation that could be due to the
modified glutamate receptor activation in the VTA DA neurons.
Thus, either the baseline elevation in AMPA/NMDA ratio or the
inability to adapt to exogenous stimuli due to the static AMPA/
NMDA ratio of GluA12/2 mice might contribute to the
hyperactive phenotype. However, the VTA DA cells are unlikely
causes for the hyperactive phenotype, since (i) GluA12/2 mice
show no difference in activation of the VTA DA cells in response
to novelty in the similar experimental setting as used here [44], (ii)
no change in locomotor activity was observed despite the sustained
elevation of AMPA/NMDA ratio in wild-type mice pretreated one
day earlier with drugs of abuse [17,45], and (iii) a mouse line
lacking GluA1 in the VTA DA cells shows both unchanged
baseline locomotor activity and AMPA/NMDA ratio [36].
The hyperactivity of GluA12/2 mice could have interfered
with the expression of conditioned place preference. Unfortunate-
ly, locomotor activity is seldom measured or reported in
conditioned place preference studies. In the study by Vezina and
Stewart [23], in which hyperactivity was suggested to mask the
expression of place preference, the testing chamber was greater in
size than that used during the conditioning phase. This difference
may have predisposed animals to enhanced drive for exploring the
testing chamber. Thus, increased exploration due to changed
environment might have caused decreased expression of condi-
Figure 6. Unchanged m-opioid receptor function in GluA12/2mice as shown by DAMGO-stimulated GTPc[35S] autoradiography. (A)
Representative autoradiographs from a control GluA1+/+ mouse showing GTPc[35S] binding in various brain regions. The figure shows basal binding,
non-specific (Non-spec.) binding in the presence of 10 mM cold GTPcS and specific 10 mM DAMGO-stimulated binding with and without the opioid
receptor antagonist naltrexone (10 mM). (B) Dose-response curves of DAMGO-stimulated GTPc[35S] binding in the caudate-putamen, nucleus
accumbens and ventral tegmental area. The data are means 6 SEM, n= 5–7. See Table 1 for EC50 and maximal stimulation values for DAMGO. Amyg,
amygdala; CPu, caudate-putamen; Hypot, hypothalamus; IC, inferior colliculus; LC, locus coeruleus; NAc, nucleus accumbens; PAG, periaqueductal
gray; SNR, substantia nigra reticulata; Thal, thalamus; VTA, ventral tegmental area.
doi:10.1371/journal.pone.0038325.g006
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tioned place preference, not the increased locomotor activity. In
the present study, we co-measured locomotor activity during the
place preference test trials. Although GluA12/2 mice had higher
locomotor activity than the GluA1+/+ mice, no correlation
between the locomotor activity and place preference was found in
our data. Locomotor activity of GluA1+/+ mice tested in Mor10-
state was equal between groups of mice that were conditioned with
either 10 mg/kg or 20 mg/kg morphine, but only 10 mg/kg
produced high expression of CPP. It cannot be fully excluded that
increased locomotor activity per se affected the expression of CPP,
but this is unlikely, since Mead and Stephens [37] have reported
the GluA12/2 mice to display both normal cocaine-induced
place preference and increased locomotor activity during the
preference test trial.
Morphine, administered in the first conditioning trial, did not
enhance locomotor activity of GluA12/2 mice, whereas it
enhanced the activity of GluA1+/+ mice. GluA12/2 mice
displayed increased habituation compared to GluA1+/+ mice. It is
possible that habituation to conditioning cages might have masked
the locomotor-activating effect of the first morphine dose. In
support to this, the lack of the morphine effect was transient and in
the second conditioning trial the morphine effect was observed
also in GluA12/2 mice. It is also possible that the lack of AMPA
receptor adaptation in GluA12/2 mice might have increased the
sedative effect of the first dose of morphine and thereby prevented
opioid-induced hyperactivity.
Since morphine-induced psychomotor sensitization and condi-
tioned place preference were observed in the GluA12/2 mice,
these behaviors can be dissociated from the glutamate receptor
neuroplasticity in the VTA DA neurons. This is supported by the
results from a transgenic mouse line with GluA1 subunits lacking
from the DA neurons, which show both unaltered place preference
and sensitization in the absence of drug-induced plasticity in VTA
DA cells [36]. However, it is possible that drug-induced glutamate
plasticity in VTA DA neurons, as expressed by the elevation in
AMPA/NMDA ratio, is linked to state-dependency, since the
drug-state seems not to be detectable as synaptic plasticity of the
VTA DA neurons in GluA1-deficient mice.
In summary, GluA12/2 animals were impaired in expressing
conditioned place preference when tested in drugged state.
Importance of state-dependency for neurobiology of addiction
has previously been suggested [1], and the present data are
important in suggesting a role for GluA1 subunit-containing
AMPA receptors in morphine state-dependency. AMPA receptor-
mediated plasticity in response to the drugs of abuse has previously
been suggested to underlie at least the initial steps in the
development of drug dependence and addiction [12], and our
data further strengthen the significance of AMPA receptors in
these processes.
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